JuneBugs Labradoodle Group

For decades, the goal of the healthcare supply chain was "Price-Based Procurement"—finding the cheapest possible version of a product. However, modern healthcare is shifting toward Value-Based Procurement (VBP). This strategy recognizes that a cheap product that fails or causes a complication is ultimately far more expensive than a high-quality, higher-priced product.

The Total Cost of Care

VBP looks at the "Total Cost of Care" rather than the "Unit Price." For instance, a hospital might choose a more expensive surgical suture that is coated in antibacterial agents. While the unit cost is 30% higher, if it reduces Surgical Site Infections (SSIs) by even 5%, the hospital saves tens of thousands of dollars in readmission costs and long-term patient care. This shift requires the supply chain team to work directly with clinicians through Value Analysis Committees (VACs).

Managing Physician Preference Items (PPI)

One of the most sensitive areas of healthcare SCM is…

Because the brain is receiving electrical signals instead of acoustic ones, it must learn how to interpret this new "language." This is known as auditory training.

• For Adults: This involves listening exercises to distinguish between speech and environmental noise.

• For Children: Intensive speech-language therapy is required to help the child map sounds to meanings and learn to speak.

• Neuroplasticity: The brain's ability to reorganize itself is the key to success. Over months of use, the "robotic" sounds begin to sound natural as the auditory cortex adapts.

When oral medications are insufficient, doctors may inject medications directly into the joint space.

• Corticosteroids: These provide rapid, short-term relief from inflammation and pain. However, frequent use (more than 3–4 times a year) is discouraged as it may accelerate joint damage.

• Hyaluronic Acid (Viscosupplementation): This mimics the natural fluid found in joints. It acts as a lubricant and shock absorber, though its effectiveness varies among patients.

• Platelet-Rich Plasma (PRP): An emerging therapy where the patient’s own blood is processed to concentrate growth factors and then re-injected into the joint to promote a healing environment.

When lifestyle modifications (diet and exercise) fail to maintain blood glucose targets—typically defined as fasting <95 mg/dL and 1-hour post-prandial <140 mg/dL—pharmacological therapy is initiated.

Insulin remains the gold standard for GDM because it does not cross the placenta, ensuring maximum safety for the fetus. Treatment usually involves a combination of intermediate-acting NPH insulin and rapid-acting insulin analogs (like Lispro or Aspart). While oral agents like Metformin or Glyburide are sometimes used due to ease of administration, they do cross the placenta. Metformin, in particular, is often used in patients with significant insulin resistance, but insulin is preferred for its precision and lack of fetal exposure.